Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
Date:11/3/2008

CALGARY, Nov. 3 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that it has achieved positive interim results in its U.K. combination REOLYSIN(R) and docetaxel clinical trial for patients with advanced cancers.

Prof. Hardev Pandha of the Royal Surrey Hospital, U.K., presented the results at the International Society for Biological Therapy of Cancer (iSBTC) annual meeting on November 1, 2008. The meeting was held in San Diego, California from October 31 - November 2, 2008.

Fourteen patients have been treated to date in the dose escalation portion of the trial and eleven patients are evaluable for response. The detailed results are summarized in the following table:

-------------------------------------------------------------------------

REOLYSIN Dose

Primary Tumour TCID(50) Cycles Best Response

-------------------------------------------------------------------------

Breast 1x10(10) 8 PR

CR in liver

-------------------------------------------------------------------------

Gastric 3x10(10) 8* PR

32% reduction in

lymph nodes

-------------------------------------------------------------------------

Mesothelioma 1x10(10) 6 Minor response

23% reduction in

lymph nodes

-------------------------------------------------------------------------

Prostate 3x10(9) 6 SD on scans

30% reduction in PSA

-------------------------------
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
2. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
3. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
4. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
5. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
6. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
7. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
8. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
9. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
10. Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... -- BioMed Realty Trust, Inc. (NYSE: BMR ) announ...s from lenders to increase the borrowing capacity ...an aggregate of $665 million, with no other change...age effective interest rate of the unsecured line ...maturity date remains August 1, 2011, which may be...
(Date:11/9/2009)...harmaceutical giants use Datafarm for production o...rm’s announcement comes on the heels of last...e Health Canada stated that, effective immediately...ory submissions for New Drug Submission (NDS) appl... Marlborough, MA (PRWEB) Novemb...
(Date:11/7/2009)...- Research projects in the areas of mathematics an...im Kunisky of Livingston, NJ and the team of Benja...ved the highest honors at the Region Five Finals o...mp; Technology, the nation,s premier high school s...m/cgi-bin/prnh/20070904/SIEMENSLOGO ) ,, Toni...
(Date:11/6/2009)...ire/ -- EUCODIS Bioscience, a company,developing, ...for the,chemical industry announced today that it ...us, the leading biopharmaceutical company in Latin...ioscience exclusive access - for the search,of enz...ction of,psychrophilic bacteria strains and other ...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...xpress, the advance online publication of the jour...ments that mark an important step toward understan... quantum mechanics. The scientists presented their...ysical Society here this week., The problem the p...in matter loses track of its quantum mechanical pr...
...stinguished Professor of Physics at Rensselaer Pol...ow of the Materials Research Society (MRS). The MR...dvancement of materials research, specifically his...nding of thin film morphological evolution., This ...llows. Lu joins a distinguished group that include...
...h,Solutions, Inc. (NYSE: MHS ) announced today th...incipal amount of 6-1/8 percent senior notes due M... amount of 7-1/8 percent,senior notes due March 15...P. Morgan Securities Inc., Banc of America Securit...presentatives of the several underwriters., Medco...
Other Biology Technology:Physicists discover how fundamental particles lose track of quantum mechanical properties 2Physicists discover how fundamental particles lose track of quantum mechanical properties 3Professor Toh-Ming Lu named fellow of the Materials Research Society 2Medco Issues $1.5 Billion of Senior Notes 2Medco Issues $1.5 Billion of Senior Notes 3
(Date:11/9/2009)...ad their hands tied because more than half of all ...n called p53. As a critical anti-cancer watchdog, ... within cells. When cells lose p53, tumors grow ag... tumors might be tough, but they,re not invincible...oratory (CSHL). The chink in the tumors, armor, ac...
(Date:11/9/2009)...s publishing a special issue "Beyond the Origin: C...arwin,s On the Origin of Species which was publish...d author of the lead article is Dr. Ulrich Kutsche... biology at the University of Kassel in Germany. A...ee of charge until 30 December 2009 on Springer,s ...
(Date:11/9/2009)...- Genencor, a division of Danisco, has won the nat... Institute of Chemical Engineers (AIChE) for its A...ethanol. Yesterday, Robert Davis, Chair of the AIC... Steele, who is Marketing Director, Biomass Enzyme... Kelley, who is Senior Engineer, Biomass Applicati...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2NewCardio Announces Master Services Agreement With Top Three Contract Research Organization 55486 1NewCardio Announces Master Services Agreement With Top Three Contract Research Organization 55486 2NewCardio Announces Master Services Agreement With Top Three Contract Research Organization 55486 3NewCardio Announces Master Services Agreement With Top Three Contract Research Organization 55486 4Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2Larta Institute Wins National Science Foundation 28NSF 29 Contract 55481 1Larta Institute Wins National Science Foundation 28NSF 29 Contract 55481 2Larta Institute Wins National Science Foundation 28NSF 29 Contract 55481 3
...f.) For our ancestors, misjudging the physical st...in painful and potentially deadly defeat. , Now... University of California, Santa Barbara has found...at enables people to determine with uncanny accura...ng in on their upper body strength. What,s more, t...
...cientists from North America and Europe will meet ... to develop the first coherent plan for studying a...ean. The plan will lay the foundations for an inte...art of the Trans-Atlantic Coral Ecosystem Study pr...iscuss recent findings and outline future research...
...international team of scientists has discovered mi...spindles, unlike anything previously seen, among s...warming event along the Atlantic coastal plain of ...biologists from the California Institute of Techno... findings in a paper published online this week in...
Other Biology News:UCSB study finds physical strength, fighting ability revealed in human faces 2UCSB study finds physical strength, fighting ability revealed in human faces 3Cold water corals conference to be held in Woods Hole 2Cold water corals conference to be held in Woods Hole 3Caltech geobiologists discover unique 'magnetic death star' fossil 2Caltech geobiologists discover unique 'magnetic death star' fossil 3
SILVER SEQUENCE Staining Reagents from Promega
Sheep Anti-Decorin Polyclonal Antibody, Unconjugated from Abcam
Mouse Complement from Equitech-Bio
...S-4P, all Programmable and Digital Orbital Shaker.... been redesigned to make every day use even easier...memory for up to 4 different programs. Its easy re...am. Furthermore, the VSOS-4P has a pulse operation...
Biology Products: